Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.13 USD | -0.13% | -.--% | +12.83% |
May. 21 | Merrimack Pharmaceuticals, Inc.(NasdaqGM:MACK) dropped from S&P Global BMI Index | CI |
May. 21 | Merrimack Pharmaceuticals, Inc.(NasdaqGM:MACK) dropped from S&P TMI Index | CI |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 192M |
---|---|---|---|---|---|
Net income 2022 | -1M | Net income 2023 | -1M | EV / Sales 2022 | - |
Net cash position 2022 | 19.44M | Net cash position 2023 | 18.88M | EV / Sales 2023 | - |
P/E ratio 2022 |
-100
x | P/E ratio 2023 |
-162
x | Employees | 27 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.81% |
1 day | -0.13% | ||
1 month | +0.87% | ||
3 months | +3.00% | ||
6 months | +18.30% | ||
Current year | +12.83% |
Managers | Title | Age | Since |
---|---|---|---|
Ulrik Nielsen
FOU | Founder | 52 | 92-12-31 |
Gary Crocker
CEO | Chief Executive Officer | 72 | 03-12-31 |
Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Crocker
CEO | Chief Executive Officer | 72 | 03-12-31 |
Director/Board Member | 46 | 19-09-18 | |
Ulrik Nielsen
FOU | Founder | 52 | 92-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.50% | 4 M€ | -5.15% | - | |
0.00% | 34 M€ | +4.11% | - |
1st Jan change | Capi. | |
---|---|---|
+12.83% | 224M | |
+55.70% | 55.7B | |
+41.08% | 39.91B | |
-5.39% | 39.57B | |
-5.56% | 28.16B | |
+16.46% | 26.3B | |
-20.56% | 18.94B | |
+33.03% | 12.17B | |
+25.85% | 12.12B | |
+2.72% | 12.12B |
- Stock Market
- Equities
- MACK Stock